Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
54.37 USD | +0.85% | -2.66% | -13.45% |
04-18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
04-17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Official Publications